CMTM Family Genes Affect Prognosis and Modulate Immunocytes Infiltration in Grade II/III Glioma Patients by Influencing the Tumor Immune Landscape and Activating Associated Immunosuppressing Pathways
Zeyu Wang(Anhui University), Quan Cheng(Central South University), Xisong Liang(Central South University), Shuwang Li(Central South University), Xun Zhang(Zaozhuang University), Hao Zhang(Northwestern Polytechnical University), Jingwei Zhang(Sichuan University), Zhixiong Liu(Central South University), Renjun Peng(Central South University), Fangkun Liu(Central South University), Kui Yang(First Affiliated Hospital of Xi'an Jiaotong University), Ziyu Dai(Central South University)
Cited by 9
Related Papers
Glioma targeted therapy: insight into future of molecular approaches
|Molecular Cancer|2022|727
CGCG clinical practice guidelines for the management of adult diffuse gliomas
|Cancer Letters|2016|650
PLGA-based biodegradable microspheres in drug delivery: recent advances in research and application
|Drug Delivery|2021|578
PARP inhibitor resistance: the underlying mechanisms and clinical implications
|Molecular Cancer|2020|548
Regulatory mechanisms of immune checkpoints PD-L1 and CTLA-4 in cancer
|Journal of Experimental & Clinical Cancer Research|2021|535